AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AstraZeneca UK Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014021
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca UK Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc is a provider of asthma treatment solutions. The company offers research and develops various novel and targeted medicines. It offers its medicines in therapeutic areas which include cardiovascular; oncology, respiratory, inflammation and autoimmunity; neuroscience and infection and vaccines. The company’s targeted therapies provide treatment of cardiovascular and metabolic diseases; oncology diseases; respiratory diseases, inflammations; infections and other neuroscience diseases. It operates in Germany, Argentina, Brazil, Canada, Chile, Colombia, India, Japan, China, Norway, Russia, the UAE, the UK and the US, among others. AstraZeneca is headquartered in London, the UK.

AstraZeneca UK Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10
Asset Transactions 12
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 12
Acquisition 13
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca UK Ltd – Key Competitors 15
AstraZeneca UK Ltd – Key Employees 16
AstraZeneca UK Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 2
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AstraZeneca UK Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
AstraZeneca UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bind Therapeutics Enters Into Co-Development Agreement With AstraZeneca For Accurin 10
Alliance Pharma Acquires Antimalarial Drug Brands From AstraZeneca UK For US$8 Million 12
AstraZeneca Completes Acquisition Of Remaining 20% Stake In AstraZeneca K.K. From Sumitomo Chemical For US$102 Million 13
AstraZeneca UK Ltd, Key Competitors 15
AstraZeneca UK Ltd, Key Employees 16

★海外企業調査レポート[AstraZeneca UK Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spineway SAS (ALSPW):医療機器:M&Aディール及び事業提携情報
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Frontera Energy Corp (FEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Frontera Energy Corp (Frontera), formerly Pacific Exploration & Production Corporation, is an upstream energy company. It carries out exploration, development and production of natural gas and crude oil. The company’s major assets include heavy oilfields of Quifa SW, Jaspe, Cajua, Quifa Nort …
  • Open Text Corporation (OTEX):企業の財務・戦略的SWOT分析
    Open Text Corporation (OTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Guitar Center, Inc.:企業の戦略的SWOT分析
    Guitar Center, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Southwestern Energy Company:企業の戦略・SWOT・財務情報
    Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report Summary Southwestern Energy Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Sino Oil and Gas Holdings Ltd (702):企業の財務・戦略的SWOT分析
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Ayala Corp (AC):企業の財務・戦略的SWOT分析
    Ayala Corp (AC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Bank Of Cyprus Public Company Ltd
    Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank Of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dalian Port (PDA) Co Ltd (2880):石油・ガス:M&Aディール及び事業提携情報
    Summary Dalian Port (PDA) Co Ltd (Dalian), a subsidiary of Dalian Port Corp Ltd is an oil and gas company that offers port and logistic services. The company offers services such as passenger and roll-on, roll-off terminal, bulk grain terminal, and related logistics services. It also provides oil an …
  • Immunicom Inc-医療機器分野:企業M&A・提携分析
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company with focus on the development of a blood filtering device for the treatment of cancer and autoimmune diseases. The company’s lead program, sTNFR Immunopheresis, is a non-drug based cancer therapy that uses a proprietary immunoads …
  • West Cornwall Pasty Co. Ltd:企業の戦略・SWOT・財務情報
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • CCL Industries Inc.:企業の戦略・SWOT・財務情報
    CCL Industries Inc. - Strategy, SWOT and Corporate Finance Report Summary CCL Industries Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Smurfit Kappa Group plc:企業の戦略・SWOT・財務情報
    Smurfit Kappa Group plc - Strategy, SWOT and Corporate Finance Report Summary Smurfit Kappa Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析
    Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • ASB Bank Limited:企業の戦略・SWOT・財務情報
    ASB Bank Limited - Strategy, SWOT and Corporate Finance Report Summary ASB Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報
    Summary Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and bi …
  • Approach Resources Inc (AREXQ):企業の財務・戦略的SWOT分析
    Approach Resources Inc (AREXQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • PT PLN (Persero):企業の戦略的SWOT分析
    PT PLN (Persero) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Arrow Electronics Inc (ARW):企業の財務・戦略的SWOT分析
    Arrow Electronics Inc (ARW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Billabong International Limited:企業のM&A・事業提携・投資動向
    Billabong International Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Billabong International Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆